3 studies found for: "Idiopathic juxtafoveal retinal telangiectasia"
Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)
Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia
Effect of Avastin in Juxtafoveal Telangiectasias
† Study has passed its completion date and status has not been verified in more than two years.